Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Fanelli

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questionsGiampietro Gasparini, Raffaele Longo, Massimo Fanelli, et al.
Oncology Reports|December 5, 2003
Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaAlessandro Morabito, Massimo Fanelli, Guido Carillio, et al.
Recenti Progressi in Medicina|December 20, 2002
[Innovative treatment in oncology]Barbara Capaccetti, Paola Bonginelli, Roberta Sarmiento, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Antiangiogenic agentsSimonetta Chiara Stani, Barbara Capaccetti, Paola Bonginelli, et al.
Expert Opinion on Investigational Drugs|July 2, 2003
Thalidomide: a new anticancer drug?Massimo Fanelli, Roberta Sarmiento, Domenico Gattuso, et al.
International Journal of Gastrointestinal Cancer|February 10, 2007
Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical courseRaffaele Longo, Alessandro Morabito, Guido Carillio, et al.
Oncology Reports|July 6, 2006
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancerAlessandro Morabito, Raffaele Longo, Domenico Gattuso, et al.
Breast Cancer Research and Treatment|November 30, 2004
Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancerAlessandro Morabito, Domenico Gattuso, Simonetta Chiara Stani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questionsGiampietro Gasparini, Raffaele Longo, Massimo Fanelli, et al.
Oncology Reports|December 5, 2003
Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaAlessandro Morabito, Massimo Fanelli, Guido Carillio, et al.
Recenti Progressi in Medicina|December 20, 2002
[Innovative treatment in oncology]Barbara Capaccetti, Paola Bonginelli, Roberta Sarmiento, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Antiangiogenic agentsSimonetta Chiara Stani, Barbara Capaccetti, Paola Bonginelli, et al.
Expert Opinion on Investigational Drugs|July 2, 2003
Thalidomide: a new anticancer drug?Massimo Fanelli, Roberta Sarmiento, Domenico Gattuso, et al.
International Journal of Gastrointestinal Cancer|February 10, 2007
Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical courseRaffaele Longo, Alessandro Morabito, Guido Carillio, et al.
Oncology Reports|July 6, 2006
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancerAlessandro Morabito, Raffaele Longo, Domenico Gattuso, et al.
Breast Cancer Research and Treatment|November 30, 2004
Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancerAlessandro Morabito, Domenico Gattuso, Simonetta Chiara Stani, et al.
Pageof 1